Incannex Healthcare Inc. (IXHL) shareholders
Close on Nov 17, 2026Market cap $21.83MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 900,000 | 7.00% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IXHL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| LPL Financial LLC | 148,178 | 1.18% | $557.15K | +77,000 | 0.00% |
| Millennium Management LLC | 95,252 | 0.76% | $358.15K | New | 0.00% |
| Jane Street Group, LLC | 78,195 | 0.62% | $294.01K | New | 0.00% |
| AdvisorShares Investments LLC | 60,868 | 0.49% | $228.86K | +36,365 | 0.03% |
| Susquehanna International Group, Llp | 28,771 | 0.23% | $108.18K | New | 0.00% |
| Commonwealth Equity Services, LLC | 14,029 | 0.11% | $52.75K | +1,917 | 0.00% |
| Citadel Advisors LLC | 10,349 | 0.08% | $38.91K | New | 0.00% |
| Osaic Holdings, Inc. | 6,376 | 0.05% | $23.97K | – | 0.00% |
| UBS Group AG | 3,610 | 0.03% | $13.57K | −36,759 | 0.00% |
| Morgan Stanley | 3,558 | 0.03% | $13.38K | +1,493 | 0.00% |
| Citigroup Inc | 2,814 | 0.02% | $10.58K | New | 0.00% |
| Quent Capital, LLC | 1,928 | 0.02% | $7.25K | – | 0.00% |
| Barclays PLC | 750 | 0.01% | $2.82K | – | 0.00% |
| Caitong International Asset Management Co., Ltd | 4 | 0.00% | $15 | New | 0.00% |
| Larson Financial Group LLC | 1 | 0.00% | $4 | −58 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 15 | 0M | 3.6% | 6 / 4 | 2 / 11 | 0M | 1M |
| Q1 2026 | 20 | 1M | 10.3% | 20 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
5 funds held IXHL in Q2 2026, 89% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of IXHL | Value | % of fund | As of |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | 60,868 | 0.49% | $228.86K | 0.52% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 9,564 | 0.08% | $32.04K | 0.00% | May 31, 2026 |
| Total Stock Market Index Trust | 243 | 0.00% | $914 | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -3,630 | -0.03% | -$13.65K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joel Latham | CEO and President, Director | 24,186,177 | 192.80% | Nov 14, 2025 |
| Joseph Swan | CFO, Treasurer and Secretary | 921,358 | 7.34% | Nov 14, 2025 |
| George Anastassov | Director | 2,456,677 | 19.58% | Nov 14, 2025 |
| Troy Valentine | Director | 12,339,120 | 98.36% | Nov 14, 2025 |
| Peter Widdows | Director | 1,957,803 | 15.61% | Nov 14, 2025 |
| Robert Clark | Director | 1,786,956 | 14.24% | Nov 14, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robert Clark Director | Nov 14, 2025 | Award | +1,686,956 | – | – | 1,786,956 |
| Peter Widdows Director | Nov 14, 2025 | Award | +1,686,956 | – | – | 1,957,803 |
| Joel Latham CEO and President, Director | Nov 14, 2025 | Award | +22,608,692 | – | – | 24,186,177 |
| George Anastassov Director | Nov 14, 2025 | Award | +1,686,956 | – | – | 2,456,677 |
| Troy Valentine Director | Nov 14, 2025 | Award | +11,302,608 | – | – | 12,001,858 |
| Joseph Swan CFO, Treasurer and Secretary | Nov 14, 2025 | Award | +869,565 | – | – | 921,358 |
| Luigi M. Barbato Chief Medical Officer | Oct 23, 2024 | Award | +100,476 | – | – | 100,476 |
| Joseph Swan CFO, Treasurer and Secretary | May 6, 2024 | Award | +50,793 | – | – | 51,793 |
| Robert Clark Director | Dec 21, 2023 | Award | +100,000 | – | – | 100,000 |
| Peter Widdows Director | Dec 21, 2023 | Award | +100,000 | – | – | 270,847 |
| George Anastassov Director | Dec 21, 2023 | Award | +100,000 | – | – | 769,721 |
| Joel Latham CEO and President, Director | Dec 21, 2023 | Award | +1,340,000 | – | – | 1,577,485 |
| Troy Valentine Director | Dec 21, 2023 | Award | +670,000 | – | – | 699,250 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Incannex Healthcare's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,181 shares on Sep 28, 2026 over the last 90 days.
See a number that looks wrong?